Clinical Trial Update: Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia

View source ↗

Summary

An update on a clinical trial investigating common noradrenergic mechanisms in Parkinson's disease and L-DOPA-induced dyskinesia. The sponsor is Aarhus Universi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Aarhus University Hospital | Conditions: Parkinson´s Disease | Status: UNKNOWN